Haemonetics Corporation Common Stock (NY:HAE)

57.49 +0.37 (+0.65%)

Streaming Delayed Price Updated: 1:47 PM EDT, May 15, 2026 Add to My Watchlist

Price and Volume

Volume	288,227
Open	57.27
Bid (Size)	57.29 (300)
Ask (Size)	57.49 (300)
Prev. Close	57.12
Today's Range	56.34 - 58.18
52wk Range	47.31 - 87.32
Shares Outstanding	51,029,618
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Small-Cap Stocks We’re Skeptical Of

Today 0:34 EDT

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Via StockStory

Haemonetics Q4 Earnings Call Highlights ↗

May 10, 2026

Haemonetics (NYSE:HAE) reported fiscal fourth-quarter revenue of $346 million, up 5% on a reported basis and 9% organically excluding CSL, as strength in its Plasma and Blood Management Technologies...

Via MarketBeat

Performance

YTD	-28.1%	-28.1%
1 Month	-4.9%	-4.9%
3 Month	-0.3%	-0.3%
6 Month	-22.2%	-22.2%
1 Year	-16.3%	-16.3%

More News

Haemonetics (HAE) Q4 2026 Earnings Transcript ↗

May 08, 2026

Via The Motley Fool

Haemonetics (NYSE:HAE) Passes the Caviar Cruise Quality Test ↗

May 05, 2026

Via Chartmill

Haemonetics (NYSE:HAE) Reports Upbeat Q1 CY2026

May 07, 2026

Via StockStory

Haemonetics Earnings: What To Look For From HAE

May 05, 2026

Via StockStory

1 Value Stock on Our Buy List and 2 Facing Headwinds

April 06, 2026

Via StockStory

What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year ↗

March 20, 2026

Via The Motley Fool

2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

March 13, 2026

Via StockStory

A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack

March 05, 2026

Via StockStory

3 Reasons HAE is Risky and 1 Stock to Buy Instead

March 03, 2026

Via StockStory

3 Profitable Stocks with Open Questions

March 01, 2026

Via StockStory

5 Revealing Analyst Questions From Haemonetics’s Q4 Earnings Call

February 12, 2026

Via StockStory

HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results

February 06, 2026

Via StockStory

Haemonetics HAE Q3 2026 Earnings Call Transcript ↗

February 05, 2026

Via The Motley Fool

Haemonetics’s (NYSE:HAE) Q4 CY2025 Sales Top Estimates, Stock Soars

February 05, 2026

Via StockStory

What To Expect From Haemonetics’s (HAE) Q4 Earnings

February 03, 2026

Via StockStory

Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: Haemonetics (NYSE:HAE)

January 28, 2026

Via StockStory

The Great Mid-Cap Rotation: Fed Rate Cuts Spark a New Bull Run for the 'Forgotten' Middle Market

January 23, 2026

Via MarketMinute

1 Russell 2000 Stock to Keep an Eye On and 2 Facing Headwinds

January 22, 2026

Via StockStory

3 Value Stocks with Open Questions

January 20, 2026

Via StockStory

1 Cash-Producing Stock Worth Your Attention and 2 Facing Challenges

January 14, 2026

Via StockStory

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

January 12, 2026

From Orchestra BioMed Holdings, Inc.

Via GlobeNewswire

1 Small-Cap Stock Worth Your Attention and 2 We Avoid

January 08, 2026

Via StockStory

3 Low-Volatility Stocks We Think Twice About

January 01, 2026

Via StockStory

Frequently Asked Questions

Is Haemonetics Corporation Common Stock publicly traded?

Yes, Haemonetics Corporation Common Stock is publicly traded.

What exchange does Haemonetics Corporation Common Stock trade on?

Haemonetics Corporation Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Haemonetics Corporation Common Stock?

The ticker symbol for Haemonetics Corporation Common Stock is HAE on the New York Stock Exchange

What is the current price of Haemonetics Corporation Common Stock?

The current price of Haemonetics Corporation Common Stock is 57.49

When was Haemonetics Corporation Common Stock last traded?

The last trade of Haemonetics Corporation Common Stock was at 05/15/26 01:47 PM ET

What is the market capitalization of Haemonetics Corporation Common Stock?

The market capitalization of Haemonetics Corporation Common Stock is 2.93B

How many shares of Haemonetics Corporation Common Stock are outstanding?

Haemonetics Corporation Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.